In this era of escalating trade tensions and geopolitical uncertainty, the U.S. cannot afford to cede another critical ...

Melbourne biotech PolyActiva says it hopes to be the next Cochlear by selling its eye drug dispensing system to millions ...

Cathie Wood’s ARK ETFs have made their daily trades for Thursday, 29 May 2025, with a notable increase in shares of CRISPR Therapeutics AG (NASDAQ: CRSP) and a continued sell-off of Adaptive ...

Intellia has leveraged its expertise in Crispr/Cas9 gene editing to advance a pipeline of in vivo and ex vivo therapies for diseases with high unmet medical needs. We believe Intellia's proprietary ...

NSW Minister for Industry and Trade Anoulack Chanthivong has returned from a successful trade mission to the Republic of ...

With 14 drugs posting double-digit sales growth in the most recent quarter, a promising obesity drug in late-stage trials, ...

Here in the U.S., many startups are facing hard questions about how they’ve grown: bloated valuations, misaligned incentives, shallow product pipelines. The contrast with Korea’s quiet biotech ascent ...

Genscript Biotech ( ($HK:1548) ) just unveiled an announcement. Genscript Biotech Corporation held its Annual General Meeting on May 29, 2025, ...

Mettler-Toledo’s capital efficiency, strong moat, and robust free cash flow make it a standout investment. Click here to find ...

BioAgilytix officials say the company's expansion strengthens its ability to support biopharma partners at every stage of ...

Taysha Gene Therapies' positive results from the REVEAL study showcase TSHA-102's promise in treating Rett Syndrome. Click ...

While a Trump administration decision to recompete several Tech Hub awards prompted frustration among supporters of the ...